TLR4 and familial pancreatic carcinoma: In animal models of hepatocellular carcinoma as well as in pancreatic cancer, LPS released from GM is able to activate Toll-like receptor 4 (TLR4) and negatively modulate immune responses (Dapito et al., 2012; Ochi et al., 2012).